Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VSIR | Q9H7M9 | 6/20 | 0.42 |
| ▸ | HTR5A | P47898 | 6/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
| ▸ | HTR1B | P28222 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3046355 | 0.93 | HDAC6 (0.40) | VSIRHTR5ADRD2DRD4DRD3 | |
| Hydrochloric Acid SCHEMBL3046520 | 0.85 | SIGMAR1 (0.43) | VSIRDRD2DRD4DRD3SIGMAR1 | |
| SCHEMBL13137114 | 0.84 | DRD2 (0.39) | VSIRHTR5ADRD2DRD4DRD3 | |
| Trifluoroacetic Acid SCHEMBL3048446 | 0.83 | HTR5A (0.41) | HTR5ADRD2DRD4DRD3HTR1A | |
| Trifluoroacetic Acid SCHEMBL3050685 | 0.83 | HTR5A (0.41) | HTR5ADRD2DRD4DRD3HTR1A | |
| Hydrochloric Acid SCHEMBL3048948 | 0.83 | DRD2 (0.38) | VSIRHTR5ADRD2DRD4DRD3 | |
| Trifluoroacetic Acid SCHEMBL3046203 | 0.82 | HTR5A (0.46) | HTR5ADRD2DRD4DRD3HTR1A | |
| SCHEMBL3050388 | 0.81 | HRH4 (0.37) | VSIRDRD2DRD4DRD3HTR2A | |
| SCHEMBL13137238 | 0.80 | SIGMAR1 (0.38) | DRD2DRD4DRD3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL3046823 | 0.80 | HRH4 (0.36) | VSIRDRD2DRD4DRD3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222345-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222345-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS | OPRL1, OPRM1, OPRK1 | VSIR 2044/4885HTR5A 190/4885DRD2 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.